T3D-959 improves cognitive function in certain patients: Study alzheimersnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzheimersnewstoday.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ A precedent-setting prevention trial in Colombia has found that the investigational medicine crenezumab did not slow or prevent decline in.
Crenezumab, an investigational medication designed to slow or prevent Alzheimer s disease, provides no cognitive benefit in patients at high genetic risk, new research suggests.
An Update on Alzheimer s Disease: New Strategies Across the Disease Continuum healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.